Your session is about to expire
← Back to Search
Renal Denervation for High Blood Pressure
Study Summary
This trial is testing whether a medical procedure to nerve endings in the kidney can lower blood pressure, and whether it is safe to do without other blood pressure medications.
- High Blood Pressure
- Cardiovascular Disease
- Vascular Disease
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You must be ready to stop taking your high blood pressure medication.You need to use oxygen support or a breathing machine all the time, except for when you sleep and have sleep apnea.Your kidney arteries are not shaped correctly.You have experienced dizziness or fainting when standing up.You have a condition called primary pulmonary hypertension.You have frequent or ongoing pain that requires taking nonsteroidal anti-inflammatory drugs (NSAIDs) at least two days a week for a month before starting the trial.You have experienced chest pain, heart attack, heart failure, stroke, or irregular heart rhythm recently or in the past.
- Group 1: Sham Procedure
- Group 2: Renal Denervation
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are the criteria for this clinical trial compatible with my medical history?
"Aspiring participants must have a pre-existing cardiovascular condition and be aged between 20 to 80. The total number of enrollees is set at 366 individuals."
Are there currently opportunities to join this research program?
"According to clinicaltrials.gov, the trial is no longer actively recruiting; it was initially posted on June 1st 2015 and last updated on October 21st 2022. That said, there are 1191 other studies enrolling patients right now."
Are individuals aged fifty and above being considered for this experiment?
"The eligibility requirements for this research set the age limit between 20 and 80, leaving out those under 18 or over 65. Conveniently, there are 82 trials available for younger patients, and 1059 studies accessible to elderly participants."
To what extent have medical facilities embraced this research endeavor?
"The trial is including patients from Centennial Medical Center in Nashville, Tennessee; Stanford Hospital and Clinics in Stanford, California; Yale New Haven Hospital in New Haven, Connecticut as well as 32 other healthcare facilities."
Who else is applying?
What state do they live in?
How old are they?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Why did patients apply to this trial?
Share this study with friends
Copy Link
Messenger